SEC Form 4 · accession 0001636178-26-000025
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Edgemond
Officer — CFO AND TREASURER
Period of report
Jun 8, 2026
Accepted (ET)
Jun 9, 2026 · 6:06 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2026 | M | 10,000 | $117.76 | A | 28,876 | D | |
| Common StockF2 | Jun 8, 2026 | S | 1,565 | $544.9334 | D | 27,311 | D | |
| Common StockF3 | Jun 8, 2026 | S | 1,989 | $546.1339 | D | 25,322 | D | |
| Common StockF4 | Jun 8, 2026 | S | 1,888 | $547.0292 | D | 23,434 | D | |
| Common StockF5 | Jun 8, 2026 | S | 2,158 | $547.9111 | D | 21,276 | D | |
| Common StockF6 | Jun 8, 2026 | S | 425 | $549.3819 | D | 20,851 | D | |
| Common StockF7 | Jun 8, 2026 | S | 1,285 | $550.0937 | D | 19,566 | D | |
| Common StockF8 | Jun 8, 2026 | S | 610 | $551.2826 | D | 18,956 | D | |
| Common StockF9 | Jun 8, 2026 | S | 80 | $551.755 | D | 18,876 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $117.76 | Jun 8, 2026 | M | 10,000 | D | Mar 15, 2023 | Mar 15, 2027 | Common Stock | 10,000 | 20,000 | D |
Explanation of responses
- F1This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- F2This transaction was executed in multiple trades at prices ranging from $544.41 to $545.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $545.47 to $546.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $546.51 to $547.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $547.52 to $548.485. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $548.59 to $549.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $549.59 to $550.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $550.63 to $551.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $551.74 to $551.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.